AnaptysBio, Inc (ANAB) stock
ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
$49.24+2.63 (+5.64%)
Close on Oct 19, 2026Market cap $1.73BP/E –Yield –
AnaptysBio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
AnaptysBio's enterprise value was $1.30B on Oct 19, 2026, against $460.76M a year earlier. Over the last 5 years it ranged from -$162.53M to $1.67B, with a median of $92.29M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $1.30B | +102.4% |
| 2025 | Dec 31, 2025 | $642.27M | – |
| 2024 | Dec 31, 2024 | -$161.53M | – |
| 2023 | Dec 29, 2023 | -$33.55M | -123.5% |
| 2022 | Dec 30, 2022 | $142.83M | -45.5% |
| 2021 | Dec 31, 2021 | $261.89M | +389.0% |
| 2020 | Dec 31, 2020 | $53.56M | – |
| 2019 | Dec 31, 2019 | -$127.50M | -119.8% |
| 2018 | Dec 31, 2018 | $643.66M | -48.9% |
| 2017 | Dec 29, 2017 | $1.26B | – |
See a number that looks wrong?